Nicholas A. Stawasz

Nick is a corporate attorney who advises clients on strategic transactions and other matters. He works with a diverse range of companies, from middle market to emerging businesses, as well as their investors and owners, on transactions such as mergers, acquisitions, dispositions, and financings. As outside general counsel for several clients, Nick provides guidance on executive decisions and operational issues, including corporate governance, internal restructurings, commercial agreements, and other matters that arise during the corporate life cycle.

Nick is particularly experienced working with private equity sponsors, their portfolio companies, family-owned and venture capital-backed companies, and other privately held companies. His balanced approach to transactions prioritizes his clients’ interests while streamlining processes whenever possible. Nick is experienced in sectors such as business and professional services, industrials, manufacturing, medical devices, and technology.

Private Equity and Portfolio Company Representations

• Represented a private equity firm in its platform acquisition of a privately held provider of business coaching and training services to field services contractors and distributors and a privately held full-service marketing agency supporting similar field services contractors and multiple add-on acquisitions.
• Represented a growth equity firm focused on fast-growing technology companies in multiple investments and exits.
• Represented a private equity-sponsored manufacturer of commercial and residential pool deck equipment and accessories in its sale to a Spanish publicly traded pool and wellness equipment company.
• Represented a private equity firm in its platform acquisition of a privately held national provider of exterior building maintenance and repair services and multiple add-on acquisitions.
• Represented a private equity fund in its acquisition of a niche manufacturing company from an affiliated private equity fund managed by the same private equity firm.
• Represented a private equity firm in its platform acquisition of a privately held tech-enabled managed security services provider, multiple add-on acquisitions, and carve-out sale of its direct guard business.
• Represented a private equity sponsored fire protection services company in multiple acquisitions and in its sale to an affiliate of a private equity fund.
• Represented a private equity sponsored provider of cloud-based contract, compliance, and revenue management solutions in its acquisition of substantially all of the assets of a Canada-based privately held cloud-based policy lifecycle management solutions provider.

Strategic Representations

• Represented an energy storage and advanced materials company in multiple financings and in the sale of its thermal management material business to a globally operating industrial and consumer goods company.
• Represented a health care analytics company in the sale of a minority ownership interest for $35 million, and option to acquire 100% of the company, and the subsequent sale of the company’s remaining ownership interest for $65 million to a Nasdaq-listed provider of health care commercial intelligence.
• Represented a clinical trial disclosure and transparency technology provider in its sale to a London Stock Exchange-listed multinational publishing, business intelligence, and exhibitions company.
• Represented a medical device company providing joint surface and preservation solutions in its sale for up to $100 million to a Nasdaq-listed joint preservation and regenerative therapies company.
• Represented a provider of digital retailing software tools to the automotive industry in its sale for more than $30 million to a Nasdaq-listed Internet-based information, technology, and communication services company.
• Represented a provider of K-12 education content and data management solutions in multiple acquisitions, debt and preferred stock financings, and sale of a majority interest via merger to an affiliate of a private equity fund.
• Represented a biopharmaceutical company in its $93 million private placement of common stock and subsequent reverse merger with a Nasdaq-listed pharmaceutical company.

• Chambers USA: Corporate/M&A, Massachusetts (2025)
• Legal 500 United States: M&A/Corporate and Commercial: Private Equity Buyouts: Middle-Market (up to $500m) (2024-2025)
• Boston Magazine, Top Lawyers List, Corporate Law (2022-2025)
• Selected for inclusion on the 2013 and 2014 Massachusetts Rising Stars lists